CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

GENBGenerate Biomedicines, Inc.

NASDAQ · Pharmaceutical Preparations
Last close $15.02 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPharmaceutical Preparations
Market cap$1.93B
RECENT INSIDER TRADES
  • 2026-09-03 · ARNOLD FRANCES (Director) · SELL
  • 2026-03-06 · Nally Michael (Chief Executive Officer) · BUY
  • 2026-03-02 · AFEYAN NOUBAR (Director) · OTHER
  • 2026-03-02 · Nally Michael (Chief Executive Officer) · OTHER
  • 2026-03-02 · Bancel Stephane (Director) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders86
Shares held100,045,749
Value$1.65B
Percent of shares outstanding77.95%
As of quarter end2026-06-30
RECENT NEWS
  • Roswell Park and Generate Biomedicines launch CAR T trial for ovarian cancer
  • Generate Biomedicines presents at Morgan Stanley healthcare conference
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Generate Biomedicines, Inc. (GENB) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit